View of Benefits of using SLGT2 Inhibitors for Patients with CDK and DM2 to Reduce Mortality Risks

Return to Article Details Benefits of using SLGT2 Inhibitors for Patients with CDK and DM2 to Reduce Mortality Risks Download Download PDF